The team highlighted that this diet is beneficial as it prioritises veggies, pulses, healthy fats and olive oil.
Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...
In the 2023-2024 election cycle alone, it is estimated that the pharmaceutical/health products industry spent $384,507,360 on ...
Coverage complications are not unusual in the U.S. healthcare system. But the challenge is magnified for these obesity ...
Patients using GLP-1 medications after joint replacement procedures to lose significant amounts of weight have a much lower risk of requiring revision surgeries, according to a Feb. 24 Medscape report ...
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.
Discover a study where findings suggest that strategies targeting visceral fat reduction may aid in overactive bladder ...
TERN-701 CARDINAL study progressing well; dose expansion expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25New ...
A civil servant who was left "crying on his knees" after being denied NHS weight loss jabs has remarkably lost nine stone and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results